CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice

Cell Transplant. 1997 Sep-Oct;6(5):505-8. doi: 10.1177/096368979700600510.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Abatacept
  • Animals
  • Animals, Newborn
  • Antigens, CD
  • Antigens, Differentiation / therapeutic use*
  • CTLA-4 Antigen
  • Cell Survival
  • Cells, Cultured
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 1 / surgery*
  • Drug Compounding
  • Immunoconjugates*
  • Immunosuppressive Agents / therapeutic use*
  • Insulin / metabolism
  • Insulin Secretion
  • Islets of Langerhans Transplantation / methods*
  • Mice
  • Mice, Inbred NOD
  • Peritoneal Cavity / cytology
  • Recombinant Fusion Proteins
  • Swine
  • Transplantation, Heterologous

Substances

  • Antigens, CD
  • Antigens, Differentiation
  • CTLA-4 Antigen
  • Ctla4 protein, mouse
  • Immunoconjugates
  • Immunosuppressive Agents
  • Insulin
  • Recombinant Fusion Proteins
  • Abatacept